Clinical Trial: Keverprazan-Minocycline Dual Therapy of Different Durations Versus Bismuth Quadruple Therapy for Helicobacter Pylori Eradication.

U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07904429) titled 'Keverprazan-Minocycline Dual Therapy of Different Durations Versus Bismuth Quadruple Therapy for Helicobacter Pylori Eradication.' on Oct. 18.

Brief Summary: This study aims to compare the efficacy and safety of keverprazan-minocycline dual therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication, focusing on eradication rates, patient adherence, and the incidence of adverse drug reactions.

Study Start Date: July 15

Study Type: INTERVENTIONAL

Condition: Helicobacter Infection

Intervention: DRUG: Minocycline

100 mg oral capsule, twice daily

DRUG: Keverprazan

20 mg oral tablet, twice daily

DRUG: Amo...